Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Speak Out Rheum: To Prescribe Is Humane (Unless You’re In Texas)

Raymond Scalettar, MD, DSc  |  Issue: November 2022  |  November 7, 2022

You both are indicted and await trial. Are you now part of the new world of the criminalization of medical care?15 You reflect on how you have spent your entire career in medicine treating all those in need, regardless of their economic circumstances. This has been your calling. Your obstetrical colleague has been known to prescribe misoprostol and mifepristone for first trimester abortions, consistent with sound medical practice. But the state has taken steps to restrict access to these life-saving medications.

The pharmacist who refused to fill your order for methotrexate for your patient aided the state in its effort to restrict access to medication by demanding written details about the patient beyond that routinely and legally required to fill a prescription. Aside from violating a federal law (i.e., the Health Insurance Portability and Accountability Act of 1996 [HIPAA]), which protects a patient’s privacy, collection of protected medical information created a paper trail the state and others could follow, leading from you and your patient to the pharmacy, then to the healthcare insurer and even to the patient’s employer.16 This invasion of the patient’s privacy and coercion of the physician is justified in Texas because the state has determined it owns, and therefore can make decisions pertaining to, a woman’s body.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

This invasion of the patient’s privacy & coercion of the physician is justified in Texas because the state has determined it owns, & therefore can make decisions pertaining to, a woman’s body.

On July 14, the Office for Civil Rights in the U.S. Dept. of Health & Human Services issued guidance that unequivocally stated that discrimination against a pregnant person, including denial of medication, is neither justified nor allowed under federal law: “Pharmacies … may not discriminate … with regard to supplying medications; making determinations regarding the suitability of a prescribed medication for a patient. … As recipients of federal financial assistance, … pharmacies are prohibited from discriminating on the basis of race, color, national origin, sex, age, and disability … under a range of federal civil rights laws. Under federal civil rights law, pregnancy discrimination includes discrimination based on current pregnancy, past pregnancy, potential or intended pregnancy, and medical conditions related to pregnancy or childbirth.”17

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Personhood

You realize you now live in a new world in which a patient with diabetes, autoimmune disease, cancer, mobility problems or neuropsychiatric issues is of no concern to a state ranking 48 out of 51 on healthcare access and quality, service use and cost, health disparities, and health outcomes.18 And your obstetrical colleague reflects how this state has little interest in the pregnant woman’s suffering: potential pain, ectopic pregnancy, fetal chromosomal abnormalities, placenta previa and increased necessity for Caesarean deliveries. The state, which ranks as the fifth worst in the nation for children, is concerned about the concept of fetal personhood, overruling concern for the rights and needs of mothers and children.19,20

Page: 1 2 3 4 5 6 | Single Page
Share: 

Filed under:EthicsLegal UpdatesOpinionProfessional TopicsSpeak Out Rheum Tagged with:abortionMethotrexatepregnancySpeak Out Rheumatology

Related Articles

    In the Wake of Dobbs v. Jackson Women’s Health Organization

    May 10, 2023

    Since the Supreme Court ruling in June 2022 overturning 50 years of precedent protecting abortion as a constitutional right (Dobbs v. Jackson Women’s Health Organization), states are enacting and implementing new laws to regulate abortion, and medical organizations and healthcare providers are assuming the large task of understanding what the new laws mean for their…

    A Better Family Plan

    October 1, 2007

    How to minimize the risks of pregnancy for women with SLE

    Contraception, Abortion & Rheumatic Disease after Dobbs

    December 12, 2022

    PHILADELPHIA—As rheumatologists, we care for patients who may or may not want to become pregnant. We aren’t obstetricians or gynecologists, but several of the drugs we prescribe for active rheumatic disease can negatively affect pregnancy outcomes. It’s imperative we understand how to effectively counsel our patients with rheumatic disease on the risks and benefits of…

    Challenges in Reproductive Health in Rheumatic Disease

    July 11, 2022

    In light of new challenges to individuals’ reproductive rights and the known challenges of clinical management of rheumatic disease patients during pregnancy, we review the current state of reproductive rheumatology and the management of patients with rheumatic disease during pregnancy.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences